CXCL12 and Brain atrophy: In this study, we demonstrated that the transplantation of cxcl12 gene-engineered stem cell CXCL12-EPCs into mouse brain at 1 week after ischemia, a considerably delayed treatment regimen, still significantly improved neural behavioral recovery and reduced brain atrophy at 5 weeks after ischemia.